Tag: Myasthenia gravis

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Myasthenia gravis

Nipocalimab Gets Priority Review for Generalized Myasthenia Gravis - eMPR.com

Added to Collection on: 2025-01-09 20:44:56

Tags for this article:

Autoimmune diseases
Monoclonal antibodies
Nipocalimab
Myasthenia gravis
GMG
Autoantibody
Orphan drugs
Immunosuppressants
Neuromuscular junction disease
Efgartigimod alfa/hyaluronidase

Click the tags to see associated articles and topics

View Article Details
FDA Approves Expanded Indication of Eculizumab for Pediatric Generalized Myasthenia Gravis

Added to Collection on: 2025-03-13 01:50:22

Tags for this article:

Monoclonal antibodies
Immunosuppressants
Orphan drugs
Eculizumab
Autoimmune diseases
Myasthenia gravis
Blood disorders
Humanized antibody
Atypical hemolytic uremic syndrome
Hemolytic–uremic syndrome
Alexion

Click the tags to see associated articles and topics

View Article Details
FDA approves Soliris for patients aged 6 years and up with generalized myasthenia gravis

Added to Collection on: 2025-03-12 17:56:11

Tags for this article:

Autoimmune diseases
Monoclonal antibodies
Orphan drugs
Eculizumab
Immunosuppressants
Myasthenia gravis
Gravis
Email
Atypical hemolytic uremic syndrome
Neuromuscular junction
Acetylcholine receptor

Click the tags to see associated articles and topics

View Article Details
Uplizna Shows Significant Efficacy, Safety Treating Generalized Myasthenia Gravis in Phase ...

Added to Collection on: 2025-04-18 17:37:26

Tags for this article:

Autoimmune diseases
Monoclonal antibodies
Orphan drugs
Myasthenia gravis
Inebilizumab
Glucocorticoid
Acetylcholine
Cytokine release syndrome

Click the tags to see associated articles and topics

View Article Details
FDA Approves Imaavy for Long Term Treatment of Generalized Myasthenia Gravis

Added to Collection on: 2025-05-01 21:07:04

Tags for this article:

Autoimmune diseases
Monoclonal antibodies
Myasthenia gravis
Nipocalimab
Autoantibody
Neonatal fragment crystallizable receptor
Acetylcholine receptor
Acetylcholine
Gravis
GMG
Congenital myasthenic syndrome
Neuromuscular junction disease
United States

Click the tags to see associated articles and topics

View Article Details
Johnson & Johnson's IMAAVY Gets FDA Approval, Taking on Top Players in Myasthenia ...

Added to Collection on: 2025-05-22 21:50:43

Tags for this article:

Orphan drugs
Monoclonal antibodies
Nipocalimab
Myasthenia gravis
Eculizumab
GMG
Efgartigimod alfa/hyaluronidase
Efgartigimod alfa
Gravis
Neonatal fragment crystallizable receptor
Batoclimab
Rozanolixizumab
Japan
United States

Click the tags to see associated articles and topics

View Article Details
Vor Bio Enters into Exclusive Global License Agreement with - GlobeNewswire

Added to Collection on: 2025-06-25 20:51:47

Tags for this article:

Autoimmune diseases
Immunology
MorphoSys
Myasthenia gravis
B-cell activating factor
Lupus
Autoimmunity
GMG
Autoantibody
Vor Bio
China

Click the tags to see associated articles and topics

View Article Details
Vor says drug licensed from RemeGen succeeded in Sjögren's study | BioPharma Dive

Added to Collection on: 2025-08-13 15:45:29

Tags for this article:

Autoimmune diseases
Myasthenia gravis
Autoantibody
Sjögren's disease
Autoimmunity
Lupus
Autoimmune disease
BAFF receptor
B-cell activating factor
China

Click the tags to see associated articles and topics

View Article Details
J&J's Nipocalimab Advances in gMG Treatment: Strategic Positioning in the Neuromuscular ...

Added to Collection on: 2025-09-19 17:43:56

Tags for this article:

Orphan drugs
Monoclonal antibodies
Autoimmune diseases
Nipocalimab
Myasthenia gravis
Neonatal fragment crystallizable receptor
GMG
Eculizumab
Gravis
Efgartigimod alfa
Food and Drug Administration
Johnson & Johnson
Johnson & Johnson's

Click the tags to see associated articles and topics

View Article Details
Myasthenia Gravis Market Outlook 2034 – Clinical Trials, Market Size, Medication ...

Added to Collection on: 2025-09-29 17:07:35

Tags for this article:

Orphan drugs
Monoclonal antibodies
Autoimmune diseases
Myasthenia gravis
Acetylcholinesterase inhibitors
Quaternary ammonium compounds
Nipocalimab
Thymectomy
Gravis
Efgartigimod alfa
MuSK protein
Pyridostigmine
Germany
Efgartigimod IV
Italy
Takeda
Kyverna Therapeutics
Dianthus Therapeutics
France
Japan
United States
United Kingdom
cartesian therapeutics
COUR Pharmaceuticals
AstraZeneca
HOFFMANN - LA ROCHE
Spain
Regeneron Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
Book a Demo